Skip to content

Public FDA record

Z-2681-2024: Alinity hq Analyzer, REF: 09P68-01

Recall record Z-2681-2024 for Abbott Laboratories. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2681-2024
Company in FDA record
Abbott Laboratories
FDA classification date
Aug 16, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

1)If Complete Blood Count with differential and reticulocyte(CBC+Diff+Retic) sample is run, then immediately following on same rack CBC+Diff sample is run, then falsely low red blood cell count may occur, generating falsely high Mean Cell Hemoglobin(MCH)/MCHC and falsely low hematocrit results. 2)Cell events may be incorrectly counted as basophil(BASO), resulting in increased BASO and %BASO counts

Source facts

Action
On 6/14/24, correction notices were sent to consignees informing them of the following: 1) Issue 1: Continue to follow the Alinity h-series Operations Manual to verify flagged results. In addition, you must select one of the two options below depending on your laboratory workflow: Option 1: Batch your CBC+DIFF+RETIC samples on an analyzer. Ensure a Background cycle is run prior to processing the next CBC+DIFF sample on that analyzer. OR Option 2: The MCHC for the laboratories are typically set between 31 36 g/dL. In the event your patient sample flags MCHC results greater than the reference range in your lab, rerun the sample and ensure the rerun does not immediately follow a CBC+DIFF+RETIC sample. 2) Issue 2: The %B high limit is typically set by the Laboratory between 2 5%. In the event your patient sample %B results are greater than the laboratory established high limit, follow the guidelines of your laboratory to rerun the sample or perform a manual slide review. Continue to follow the Alinity h-series Operations Manual to verify flagged results. 3) Provide a copy of the accompanying Product Correction letter to the laboratory manager, supervisor or health professional responsible for the impacted product. 4) If you have forwarded the product listed above to other laboratories, please inform them of this Product Correction and provide to them a copy of this letter. 5) Retain this letter for your laboratory records. 6) Complete and return the Customer Reply Form via email to PMS@abbott.com Your Abbott representative will be scheduling a mandatory upgrade of your Alinity hq Analyzer to install software versions(Country): 5.10 (US), 5.9 (Canada and South Korea), 5.8 (OUS except Canada and South Korea). If you or any of the health care providers you serve have questions regarding this information, please contact Customer Service at 1-877-4ABBOTT (available 24 hours a day, 7 days a week).
Initiated
2024-06-14
Root cause
Software design
Distribution
Worldwide - US Nationwide distribution in the states of NY, OK, NC and the countries of ALBANIA, ARGENTINA, AUSTRALIA, BANGLADESH, BELGIUM, BOSNIA AND HERZEGOVINA, Botswana, BRAZIL, BULGARIA, CANADA, CAYMAN ISLANDS, CHILE, COLOMBIA, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT, FRANCE, GERMANY, GREECE, HONDURAS, HONG KONG, HUNGARY, INDIA, INDONESIA, ITALY, JAMAICA, JAPAN, JORDAN, KUWAIT, LEBANON, LITHUANIA, MALAYSIA, MALDIVES, MEXICO, NETHERLANDS, NORWAY, OMAN, PAKISTAN, PANAMA, PHILIPPINES, POLAND, PORTUGAL, QATAR, ROMANIA, SAUDI ARABIA, SERBIA, SLOVENIA, SOUTH AFRICA, SOUTH KOREA, SPAIN, SWITZERLAND, THAILAND, TRINIDAD & TOBAGO, TURKEY, UAE, UK, URUGUAY, VIETNAM.
Recall number
Z-2681-2024
Recall status
Open, Classified
CDRH record ID
208939
FDA classified
2024-08-16
Recall event number
94958

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗